Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: Binding antibodies predict neutralizing antibody development
H. Hegen*, A. Millonig, A. Bertolotto, M. Comabella, G. Giovanonni, M. Guger, M. Hoelzl, M. Khalil, J. Killestein, R. Lindberg, S. Malucchi, M. Mehling, X. Montalban, C. H. Polman, D. Rudzki, F. Schautzer, F. Sellebjerg, P. S. Sørensen, F. Deisenhammer
*Autor corresponent d’aquest treball
- Medical University of Innsbruck (MUI)
- Azienda Ospedaliera-Universitaria San Luigi Gonzaga
- Hospital Universitari Vall d'Hebron (HUVH)
- Queen Mary University of London (QMU)
- Johannes Kepler University Linz
- Medizinischen Universität Graz - Medical University of Graz
- Vrije Universiteit Amsterdam (VU)
- University of Basel
- Centre d'Esclerosi Mútiple de Catalunya (Cemcat)
- Clinical Department of Neurology
- University of Copenhagen
Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts
43
!!Link opens in a new tab
Cites
(Scopus)